000			05029nam a22004094a 4500
001			ebr10075614
003			CaPaEBR
006			m u
007			cr cn|||||||||
008			040922s2005 nyua sb 001 0 eng
010			_z 2004022295
020			_z0814408451
040			_aCaPaEBR _cCaPaEBR
035			_a(OCoLC)614665643
050	1	4	_aRA418.5.M4 _bD49 2005eb
082	0	4	_a610/.28 _222
100	1		_aDeyo, Richard A.
245	1	0	_aHope or hype _h[electronic resource] : _bthe obsession with medical advances and the high cost of false promises / _cRichard A. Deyo, Donald L. Patrick.
260			_aNew York : _bAMACOM, American Management Association, _cc2005.
300			_axvi, 335 p. : _bill.
504			_aIncludes bibliographical references (p. [291]-326) and index.
505	0		_aCan there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
505	0		_aCan there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
650		0	_aMedical innovations _zUnited States _xEvaluation.
650		0	_aMedical technology _zUnited States _xEvaluation.
650		0	_aMedical care _xTechnological innovations _zUnited States _xEvaluation.
650		0	_aMedical care _zUnited States _xEvaluation.
650		0	_aMedical innovations _xEconomic aspects _zUnited States.
650		0	_aMedical technology _zUnited States _xCost effectiveness.
650		0	_aMedical care _xTechnological innovations _zUnited States _xCost effectiveness.
650		0	_aMedical care, Cost of _zUnited States.
655		7	_aElectronic books. _2local
700	1		_aPatrick, Donald L.
710	2		_aebrary, Inc.
856	4	0	_uhttp://site.ebrary.com/lib/rucke/Doc?id=10075614 _zAn electronic book accessible through the World Wide Web; click to view
999			_c45655 _d45655